Dr Lalchandani Labs Ltd

Dr Lalchand. Lab Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Lalchandani Labs Ltd

₹ 20.6 -2.00%
04 Jul - close price
lalchandanipathlab.com BSE - SME: 541299
About

Incorporated in 2011, Dr. Lalchandani Labs Ltd is in the business of running laboratories
for pathological investigations[1]

Key Points

Business Overview:[1][2][3]
DLLL is a NABL accredited company with 5 Self-sufficient Labs and 15 collection centers across Delhi/NCR. It is empaneled for CGHS (South, North and East Block), DJB, MCD, DDA etc. and provides diagnostic and related healthcare tests and services. Company owns, runs laboratories for carrying out pathological investigations of various branches of Bio-Chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Virology, Cytology, other pathological Investigations and Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA & Genetic Testing etc.

Website BSE
  • Market Cap ₹ 8.92 Cr.
  • Current Price ₹ 20.6
  • High / Low ₹ 28.9 / 0.00
  • Stock P/E 21.2
  • Book Value ₹ 23.0
  • Dividend Yield 0.00 %
  • ROCE 3.70 %
  • ROE 4.31 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.90 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -3.60%
  • The company has delivered a poor sales growth of -6.11% over past five years.
  • Company has a low return on equity of -6.62% over last 3 years.
  • Company might be capitalizing the interest cost
  • Company has high debtors of 431 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns
Loading peers table ...

Half Yearly Results

Figures in Rs. Crores

Mar 2019 Sep 2019 Mar 2020 Sep 2020 Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
2.64 3.03 3.07 2.71 7.07 8.02 3.26 2.28 2.76 2.73 2.08 2.13 2.33
1.95 2.30 2.53 2.14 5.40 6.07 2.81 2.46 2.50 2.38 1.04 1.59 1.82
Operating Profit 0.69 0.73 0.54 0.57 1.67 1.95 0.45 -0.18 0.26 0.35 1.04 0.54 0.51
OPM % 26.14% 24.09% 17.59% 21.03% 23.62% 24.31% 13.80% -7.89% 9.42% 12.82% 50.00% 25.35% 21.89%
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.24 0.00 0.00
Interest 0.05 0.09 0.09 0.05 0.30 0.24 0.33 0.48 0.51 0.11 0.28 0.05 0.03
Depreciation 0.20 0.21 0.22 0.23 0.29 0.28 0.30 0.33 0.34 0.33 0.29 0.28 0.28
Profit before tax 0.45 0.43 0.23 0.29 1.08 1.43 -0.18 -0.98 -0.59 -0.09 0.71 0.21 0.20
Tax % 26.67% 0.00% 82.61% 24.14% 27.78% 25.17% -22.22% 0.00% 0.00% 0.00% 0.00% 23.81% -35.00%
0.34 0.43 0.04 0.23 0.79 1.07 -0.13 -0.97 -0.59 -0.09 0.71 0.15 0.27
EPS in Rs 0.78 0.99 0.09 0.53 1.82 2.47 -0.30 -2.24 -1.36 -0.21 1.64 0.35 0.62
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2.79 5.26 6.10 9.78 11.28 5.04 4.81 4.45
2.17 4.06 4.84 7.54 8.81 4.95 4.59 3.40
Operating Profit 0.62 1.20 1.26 2.24 2.47 0.09 0.22 1.05
OPM % 22.22% 22.81% 20.66% 22.90% 21.90% 1.79% 4.57% 23.60%
0.03 0.01 0.00 0.00 0.00 0.00 1.40 0.01
Interest 0.16 0.14 0.18 0.35 0.60 0.99 0.38 0.09
Depreciation 0.13 0.35 0.42 0.52 0.59 0.66 0.62 0.56
Profit before tax 0.36 0.72 0.66 1.37 1.28 -1.56 0.62 0.41
Tax % 25.00% 26.39% 28.79% 26.28% 28.12% 0.00% 0.00% -2.44%
0.26 0.53 0.47 1.01 0.93 -1.56 0.62 0.42
EPS in Rs 0.89 1.22 1.08 2.33 2.15 -3.60 1.43 0.97
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: -6%
3 Years: -27%
TTM: -7%
Compounded Profit Growth
10 Years: %
5 Years: -2%
3 Years: -23%
TTM: 155%
Stock Price CAGR
10 Years: %
5 Years: 15%
3 Years: -3%
1 Year: -15%
Return on Equity
10 Years: %
5 Years: 0%
3 Years: -7%
Last Year: 4%

Balance Sheet

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 2.93 4.33 4.33 4.33 4.33 4.33 4.33 4.33
Reserves 0.40 3.73 4.21 5.22 6.15 4.59 5.21 5.62
1.88 0.90 1.76 4.04 5.15 6.40 3.48 4.07
1.00 1.18 1.63 1.61 2.49 2.40 1.97 1.73
Total Liabilities 6.21 10.14 11.93 15.20 18.12 17.72 14.99 15.75
2.06 3.28 3.47 5.24 5.75 5.39 3.99 3.51
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.24 0.24 0.24 0.24 0.24 0.24 0.41 0.27
3.91 6.62 8.22 9.72 12.13 12.09 10.59 11.97
Total Assets 6.21 10.14 11.93 15.20 18.12 17.72 14.99 15.75

Cash Flows

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.58 -0.45 -0.10 1.19 2.01 0.00 -0.22 0.44
-1.29 -1.95 -0.53 -2.26 -1.53 -0.20 1.00 0.06
1.57 3.51 0.85 1.71 0.16 -0.23 -1.59 0.50
Net Cash Flow 0.85 1.12 0.23 0.64 0.64 -0.43 -0.81 1.00

Ratios

Figures in Rs. Crores

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 149.14 126.99 199.25 148.54 136.55 359.93 356.65 431.44
Inventory Days 167.03 233.36 158.70 68.75 191.07 458.51 255.15 490.47
Days Payable 426.86 406.89 355.48 97.06 175.15 404.21 217.94 365.00
Cash Conversion Cycle -110.69 -46.54 2.47 120.23 152.47 414.23 393.86 556.91
Working Capital Days 168.76 170.70 209.43 132.86 123.93 287.51 402.18 490.49
ROCE % 12.14% 8.72% 14.40% 12.87% -3.68% -2.68% 3.70%

Shareholding Pattern

Numbers in percentages

44 Recently
Sep 2019Mar 2020Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025
60.78% 60.78% 60.78% 60.78% 60.78% 60.78% 60.78% 60.78% 60.78% 60.78% 57.18% 48.32%
39.22% 39.22% 39.22% 39.22% 39.22% 39.22% 39.23% 39.22% 39.21% 39.22% 42.82% 51.68%
No. of Shareholders 144143143143151157162164159165181246

Documents

Announcements

Annual reports

DRHP